Urine Prostate Screening Integrated With MRI for Early Detection of Prostate Cancer, UPRISE Trial
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This clinical trial tests how well a urine prostate cancer screening test, My Prostate Score 2 (MPS2), integrated with magnetic resonance imaging (MRI) works for early detection of prostate cancer. MPS2 is an investigational urine-based test designed to help identify the likelihood of having aggressive prostate cancer. MPS2 testing works by measuring specific early detection biomarkers that include genetic information. This next-generation test aims to address a major challenge in prostate cancer care-detecting only the cancers that truly need treatment. Results may lead to paradigm shifts in early detection algorithms and reduce reliance on MRI and biopsy.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Mężczyźni w wieku 50-75 lat
- •Wynik PSA między 3-20 ng/ml wykonany w ostatnich 3 miesiącach
- •Stan zdrowia pozwalający na wszystkie procedury badania
- •Brak biopsji prostaty w ostatnich 4 latach
- •Brak badania MRI prostaty w ostatnich 2 latach
- •Możliwość podpisania świadomej zgody
✗ Disqualifies
- •Historia diagnozy raka prostaty
- •Przeciwwskazania do badania MRI (na przykład klaustrofobia, rozrusznik serca)
- •Przeciwwskazania do biopsji prostaty
- •Wcześniejsza operacja wymiany biodra lub metalowe implanty w okolicy miednicy
Simplified criteria — AI translation
Trial details
- Minimum age
- 50 Years
- Maximum age
- 75 Years
- Last updated (source)
- October 15, 2026
- Sex
- Male only
Therapies / drugs in trial
Locations (1)
University of Michigan Rogel Cancer Center
Ann Arbor, United States
Trial contact
Uprise StudyTeam
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 10/16/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.